Scientific article
OA Policy
English

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

Published inRheumatology, vol. 54, no. 6, p. 1074-1079
Publication date2015
Abstract

Under the auspices of the European League Against Rheumatism (EULAR), a study group of investigators representing European biologic DMARD (bDMARD) registers was convened. The purpose of this initial assessment was to collect and compare a cross section of patient characteristics and collate information on the availability of potential confounders within these registers.

Citation (ISO format)
KEARSLEY-FLEET, Lianne et al. The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers. In: Rheumatology, 2015, vol. 54, n° 6, p. 1074–1079. doi: 10.1093/rheumatology/keu446
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN1462-0324
604views
305downloads

Technical informations

Creation27/01/2015 15:32:00
First validation27/01/2015 15:32:00
Update24/01/2025 14:34:23
Status update24/01/2025 14:34:23
Last indexation24/01/2025 14:42:24
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack